233 related articles for article (PubMed ID: 31968219)
1. DNA damage response and resistance of cancer stem cells.
Abad E; Graifer D; Lyakhovich A
Cancer Lett; 2020 Apr; 474():106-117. PubMed ID: 31968219
[TBL] [Abstract][Full Text] [Related]
2. Therapy resistance mediated by cancer stem cells.
Steinbichler TB; Dudás J; Skvortsov S; Ganswindt U; Riechelmann H; Skvortsova II
Semin Cancer Biol; 2018 Dec; 53():156-167. PubMed ID: 30471331
[TBL] [Abstract][Full Text] [Related]
3. CD10
Ffrench B; Gasch C; Hokamp K; Spillane C; Blackshields G; Mahgoub TM; Bates M; Kehoe L; Mooney A; Doyle R; Doyle B; O'Donnell D; Gleeson N; Hennessy BT; Stordal B; O'Riain C; Lambkin H; O'Toole S; O'Leary JJ; Gallagher MF
Cell Death Dis; 2017 Oct; 8(10):e3128. PubMed ID: 29048400
[TBL] [Abstract][Full Text] [Related]
4. Enhanced DNA damage response through RAD50 in triple negative breast cancer resistant and cancer stem-like cells contributes to chemoresistance.
Abad E; Civit L; Potesil D; Zdrahal Z; Lyakhovich A
FEBS J; 2021 Apr; 288(7):2184-2202. PubMed ID: 33090711
[TBL] [Abstract][Full Text] [Related]
5. Side population and cancer stem cells: therapeutic implications.
Moserle L; Ghisi M; Amadori A; Indraccolo S
Cancer Lett; 2010 Feb; 288(1):1-9. PubMed ID: 19523754
[TBL] [Abstract][Full Text] [Related]
6. Radiation-induced DNA damage response and resistance in colorectal cancer stem-like cells.
Anuja K; Chowdhury AR; Saha A; Roy S; Rath AK; Kar M; Banerjee B
Int J Radiat Biol; 2019 Jun; 95(6):667-679. PubMed ID: 30753097
[No Abstract] [Full Text] [Related]
7. Survival of the fittest: cancer stem cells in therapeutic resistance and angiogenesis.
Eyler CE; Rich JN
J Clin Oncol; 2008 Jun; 26(17):2839-45. PubMed ID: 18539962
[TBL] [Abstract][Full Text] [Related]
8. Cancer stem cell (CSC) resistance drivers.
Najafi M; Mortezaee K; Majidpoor J
Life Sci; 2019 Oct; 234():116781. PubMed ID: 31430455
[TBL] [Abstract][Full Text] [Related]
9. Cancer stem cells: an approach to identify newer therapeutic targets.
Srivastava S; Krishna S
J Stem Cells; 2009; 4(2):123-31. PubMed ID: 20232597
[TBL] [Abstract][Full Text] [Related]
10. Cancer stem cells and chemoresistance: The smartest survives the raid.
Zhao J
Pharmacol Ther; 2016 Apr; 160():145-58. PubMed ID: 26899500
[TBL] [Abstract][Full Text] [Related]
11. Cancer Stem Cells: Root of the Evil.
Erkisa M; Karakas D; Ulukaya E
Crit Rev Oncog; 2019; 24(1):69-87. PubMed ID: 31679222
[TBL] [Abstract][Full Text] [Related]
12. Curcumin attenuates resistance to irinotecan via induction of apoptosis of cancer stem cells in chemoresistant colon cancer cells.
Su P; Yang Y; Wang G; Chen X; Ju Y
Int J Oncol; 2018 Sep; 53(3):1343-1353. PubMed ID: 29956726
[TBL] [Abstract][Full Text] [Related]
13. The molecular mechanisms underlying the therapeutic resistance of cancer stem cells.
Kim JK; Jeon HY; Kim H
Arch Pharm Res; 2015 Mar; 38(3):389-401. PubMed ID: 25502807
[TBL] [Abstract][Full Text] [Related]
14. Cancer stem cells--important players in tumor therapy resistance.
Colak S; Medema JP
FEBS J; 2014 Nov; 281(21):4779-91. PubMed ID: 25158828
[TBL] [Abstract][Full Text] [Related]
15. Cancer stem cells: A review from origin to therapeutic implications.
Atashzar MR; Baharlou R; Karami J; Abdollahi H; Rezaei R; Pourramezan F; Zoljalali Moghaddam SH
J Cell Physiol; 2020 Feb; 235(2):790-803. PubMed ID: 31286518
[TBL] [Abstract][Full Text] [Related]
16. Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation.
Lee SY; Jeong EK; Ju MK; Jeon HM; Kim MY; Kim CH; Park HG; Han SI; Kang HS
Mol Cancer; 2017 Jan; 16(1):10. PubMed ID: 28137309
[TBL] [Abstract][Full Text] [Related]
17. Proteoglycans and glycosaminoglycans as regulators of cancer stem cell function and therapeutic resistance.
Vitale D; Kumar Katakam S; Greve B; Jang B; Oh ES; Alaniz L; Götte M
FEBS J; 2019 Aug; 286(15):2870-2882. PubMed ID: 31230410
[TBL] [Abstract][Full Text] [Related]
18. Inhibitors of Cancer Stem Cells.
García-Rubiño ME; Lozano-López C; Campos JM
Anticancer Agents Med Chem; 2016; 16(10):1230-9. PubMed ID: 27025655
[TBL] [Abstract][Full Text] [Related]
19. Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis.
Marquardt S; Solanki M; Spitschak A; Vera J; Pützer BM
Semin Cancer Biol; 2018 Dec; 53():90-109. PubMed ID: 29966677
[TBL] [Abstract][Full Text] [Related]
20. Targeting cancer stem cell-specific markers and/or associated signaling pathways for overcoming cancer drug resistance.
Ranji P; Salmani Kesejini T; Saeedikhoo S; Alizadeh AM
Tumour Biol; 2016 Oct; 37(10):13059-13075. PubMed ID: 27561758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
